J0135 HCPCS Level II code: Injection, adalimumab, 20 mg
CMS terminated J0135: its last date of service was Dec 31, 2024. It stays here for looking up older claims; newer services need a current code.
Official description
J0135Injection, adalimumab, 20 mg
Short description: Adalimumab injection
HCPCS · United States
Medicare details
The indicators CMS publishes with J0135 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Added
- Jan 1, 2005
- Terminated after
- Dec 31, 2024
Where J0135 sits
- 1J codesDrugs administered other than orally
- 2Terminated J0135Injection, adalimumab, 20 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
Is HCPCS code J0135 still valid?
No. CMS terminated J0135; its last date of service was Dec 31, 2024. It is listed for looking up services from before then. Use a current code for newer services.
Does Medicare cover J0135?
CMS lists J0135’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J0135
All J codesJ0129Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)J0130Injection abciximab, 10 mgJ0131Injection, acetaminophen, not otherwise specified,10 mgJ0132Injection, acetylcysteine, 100 mgJ0133Injection, acyclovir, 5 mgJ0134Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mgJ0136Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mgJ0137Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mgJ0138Injection, acetaminophen 10 mg and ibuprofen 3 mgJ0139Injection, adalimumab, 1 mgJ0150Injection, adenosine for therapeutic use, 6 mg (not to be used to report any adenosine phosphate compounds, instead use a9270)J0151Injection, adenosine for diagnostic use, 1 mg (not to be used to report any adenosine phosphate compounds, instead use a9270)